Literature DB >> 7580120

Influence of chromosomal position and copy number of a white-directed ribozyme gene on the suppression of eye pigmentation in Drosophila melanogaster.

J C Heinrich1, M Tabler, C Louis.   

Abstract

Different strains of transgenic Drosophila melanogaster carrying one, two, or three copies of a heat-shock promoter 70 (hsp70)-driven catalytic antisense RNA gene, directed against the white gene, were investigated for the expression level of ribozyme RNA. It was found that the steady-state concentrations of the hammerhead ribozyme were proportional to the copy number of the genes and that the suppressive effect on eye pigment accumulation was dosage dependent. In a further experiment, a D. melanogaster strain, deficient in eye pigmentation caused by a deletion of the white gene, was used for P element-mediated germline transformation: the transposon used contained the hsp70-driven, white-directed ribozyme gene and, on the same DNA, the mini-white gene under its own promoter. The spatial coupling of the transcription of ribozyme and target RNA resulted in more effective ribozyme-mediated inhibition of eye pigmentation under heat-shock conditions. These effects were dependent on the chromosomal integration site of the transposon.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7580120     DOI: 10.1089/ard.1995.5.155

Source DB:  PubMed          Journal:  Antisense Res Dev        ISSN: 1050-5261


  3 in total

1.  Essential role of mitochondrially encoded large rRNA for germ-line formation in Drosophila embryos.

Authors:  T Iida; S Kobayashi
Journal:  Proc Natl Acad Sci U S A       Date:  1998-09-15       Impact factor: 11.205

2.  Regulation of CAT protein by ribozyme and antisense mRNA in transgenic mice.

Authors:  D L Sokol; R J Passey; A G MacKinlay; J D Murray
Journal:  Transgenic Res       Date:  1998-01       Impact factor: 2.788

Review 3.  Antisense approaches to the gene therapy of cancer--'Recnac'.

Authors:  I Gibson
Journal:  Cancer Metastasis Rev       Date:  1996-09       Impact factor: 9.264

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.